This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to ...

Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry (ABPI) calling up its members to speak on the record, ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

Relative to drug developers, medical device makers have outperformed amid the turmoil of the Trump administration's healthcare reforms.

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

Midtown-based drug discovery startup GRIN Therapeutics has reached a deal with Angelini Pharma to commercialize its signature ...

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...

The president’s proposed 25 percent tariffs on pharmaceutical imports will be catastrophic. There are other options to bring ...

Biocon is gearing up to become a dominant player in the diabetes and obesity drug market. This comes as the pharma world ...

Arkansas is setting a bold precedent in the fight against Big Pharma, as Governor Sarah Huckabee Sanders has signed legislation that prohibits Pharmacy Benefit Managers (PBMs) from owning pharmacies ...